
    
      Subjects 19-85 years old will receive a single intra-articular (IA) injection of DUROLANEÂ®
      3mL given for the relief of pain in the treatment of symptomatic osteoarthritis (OA) of the
      shoulder followed over a 26-week time period.
    
  